Executive Officers

James Rhee, 61
Chief Executive Officer, Chairman and Director

Mr. Rhee has been a partner of SparkLabs Group since 2022, and has been an advisor and mentor to SparkLabs Group since its founding in 2013 and serves as the CEO of the SparkLabs Group’s SPAC venture. Mr. Rhee is also the founder and previous president of Aero K Holdings Company, a technology focused aviation industry startup founded in 2016. Prior to Aero K Holdings Company, he served as chief executive officer of Air Asia, North Asia from November 2012 to March 2016. Prior to AirAsia, Mr. Rhee served as senior advisor to Octave Private Equity from January 2012 to July 2014, vice president and general manager of Tyco Electronics global PC business from July 2010 to December 2011, executive director of Dell’s Asia Pacific/Japan PC business and Enterprise Solutions Marketing from May 2003 to June 2010, engagement manager at McKinsey & Company from August 2000 to May 2003, and research officer at the International Monetary Fund from September 1989 to June 1998. Mr. Rhee received an M.B.A. (Gamma Beta Sigma) from Kellogg School of Management at Northwestern University in 2000 and a B.S. in Economics from the University of Minnesota in 1997.

Ho Min (Jimmy) Kim, 52
Chief Finance Officer and Director

Mr. Kim co-founded and has served as a partner at SparkLabs Group since May 2012. Within SparkLabs Group, Mr. Kim has also served as General Partner of Sparklabs since 2018, and on the investment committess of Sparklabs Korea Funds, Sparklabs Global Funds and Sparklabs Ignition Fund since 2012. Mr. Kim also co-founded N3N, an IoT platform company and served as its president from May 2012 to December 2018. From May 2008 to February 2012, he served as head of portal and webservices for Nexon Corp., an online gaming company. Mr. Kim received a B.S. in Biomedical Engineering from Northwestern University in 1993 and an M.S. in Life Sciences from Korea Advanced Institute of Science and Technology, KAIST in 1997.

Kurtis Jang, 54
Chief Operating Officer and Director

Prior to joining us, Mr. Jang was with Prudential Life Insurance Company of Korea, Ltd., a subsidiary of Prudential Financial, Inc., a provider of insurance, investment management and other financial products and services, from April 2015 to September 2020, where he served as chief executive officer. From April 2010 to April 2015, he served as chief executive head of Chubb Korea, an insurance provider affiliated with Chubb Limited. Mr. Jang received a B.S. in Managerial Economics from the University of Illinois, Urbana-Champaign in 1990.

Board of Directors

Cuong Viet Do, 57
Director

Mr. Do is currently President and Chief Executive Officer of BioVie Inc., a clinical stage biotech company listed on the NASDAQ that develops innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. He also served as president, global strategy group, at Samsung Group, a multinational conglomerate, from February 2015 to February 2021. Mr. Do previously served as chief strategy officer for Merck & Co., Inc., Tyco Electronics, and Lenovo. Previous to that, he was a director and senior partner at McKinsey & Company, where he spent 17 years in the healthcare, high tech and corporate finance practices. He received a B.A. from Dartmouth College in 1988 and an M.B.A. from the Tuck School of Business at Dartmouth in 1989.

Shin-Bae Kim, 68
Director

Mr. Kim has also served as an advisor for Afiniti, Inc, a US AI solution startup since Jun 2020, and for Samkwang Biotree Group since April 2022. He also served as a director of POSCO, a steel manufacturing company, from March 2017 to March 2022. He previously served as vice chairman of SK Group, a conglomerate composed of 92 subsidiary companies, from March 2009 to February 2013. From March 2004 to March 2009, Mr. Kim served as president and chief executive officer of SK Telecom, a leading telecom service provider in Korea. He received a B.S. in Industrial Engineering from Seoul National University in 1978, an M.S. in Industrial Engineering from KAIST in 1980 and an M.B.A. from the Wharton School of the University of Pennsylvania in 1985.

Willy Lan, 47
Director 

Mr. Lan co-founded Cambium Grove Capital in 2019, a Hong Kong based investment firm focused on global investments in venture, private equity, and alternative credit, and has been serving as its partner since then. Mr. Lan has invested across a full spectrum of asset classes including venture, private equity, structured credit and distressed trading, and through different investment cycles. Mr. Lan is also an active angel investor and has served on the advisory board of Jaarvis Accelerator, which he co-founded, and Antler Accelerator. Prior to founding Cambium Grove Capital, Mr. Lan was a portfolio manager with Och-Ziff Capital Asia (now Sculptor Capital Management) from February 2008 to March 2009 and from February 2011 to October 2015. Before that, he was a founding member of SC Lowy and served as its head of distribution from September 2009 to February 2011. Prior to that, he was a founding member, of and served as the director for Abax Global Capital from April 2007 to February 2008. Mr. Lan started his career in 2001 with Merrill Lynch’s Global Private Equity Group. He received a B.A. in Business Economics and International Relations from Brown University in 1999.

Tony Ling, 49
Director 

Mr. Ling has served as a venture partner of SparkLabs Taipei, a startup accelerator firm and affiliate of SparkLabs Group Management, since March 2017. From February 2014 to January 2016, Mr. Ling served as president of iQ License LLC, an online platform for manufacturers and retailers. From February 2005 to February 2014, he served as a principal, director, and managing director at Silver Lake Partners, a private equity firm. Mr. Ling received a B.A. in Economics from Harvard University in 1996 and an M.B.A. from Harvard Business School in 2002.

Catherine Mohr, 55
Director 

Dr. Mohr has been with Intuitive Surgical, Inc., a developer and manufacturer of surgical robotic products designed to improve clinical outcomes of patients, since May 2016, where she has served in various executive roles, including as vice president, strategy from October 2015 to August 2018. Through Intuitive Surgical, Dr. Mohr has been seconded as the president of Intuitive Foundation, a nonprofit organization focused on the promotion of health and advancing education, since August 2018. Since November 2022, Dr. Mohr has served on the board of directors of Aroa Biosurgery, a soft tissue regeneration company, and Avis Technologies, a medical device startup. Dr. Mohr has also served on the board of directors of FINCA International, a non-profit, microfinance organization, since February 2020, and Carta Healthcare, a software company which specializes in medical data abstraction, since July 2021. She received a B.S. and an M.S. in Mechanical Engineering from the Massachusetts Institute of Technology in 1990 and 1992, respectively, and an M.D. from Stanford University School of Medicine in 2006.